A Study of S6G5T-3 in the Treatment of Acne Vulgaris

Inclusion Criteria:

1. Participant must sign an Institutional Review Board (IRB) approved written informedconsent for this study.
2. Male and female 9 years of age and older.
3. Have 2 or fewer cysts or nodules.

Exclusion Criteria:

1. More than 2 acne nodules or cysts (defined as an inflammatory lesion greater than orequal to 5 millimeter (mm) in diameter).
2. Acne conglobata, acne fulminans, and secondary acne (for example, chloracne,drug-induced acne).
3. History of blood dyscrasia (for example, leukemia, haemophilia, sickle cell anemia,multiple myeloma).
4. Underlying disease that requires the use of interfering topical or systemic therapy.
5. Other dermatological conditions that require the use of interfering topical orsystemic therapy or that might interfere with study assessments such as, but notlimited to, atopic dermatitis, perioral dermatitis, or rosacea.